Whalegun
Home

Neurocrine Biosciences NBIX spent $830K on lobbying in Q1 2024 · Medicare, Health Issues and 2 more issues

Trade details

Type
Lobbying report
Amount
$830,000
Quarter
Q1 2024
Stock
Neurocrine Biosciences NBIX
Client
Neurocrine Biosciences
Reported
24/04/22

Up 6.4% from last quarter

What else happened in Neurocrine Biosciences around then

Filed or reported within 30 days of the trade day · 24/03/01~24/04/30

Neurocrine Biosciences's other lobbying reports